The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study
Journal
International Journal of Cardiology
Date Issued
2020-11-01
Author(s)
Zhang, Dongfeng
Song, Xiantao
Raposeiras-Roubín, Sergio
Abu-Assi, Emad
Henriques, Jose Paulo Simao
D'Ascenzo, Fabrizio
Saucedo, Jorge
González-Juanatey, José Ramón
Wilton, Stephen B
Kikkert, Wouter J
Nuñez-Gil, Iván
Ariza-Sole, Albert
Alexopoulos, Dimitrios
Liebetrau, Christoph
Kawaji, Tetsuma
Moretti, Claudio
Huczek, Zenon
Nie, Shaoping
Fujii, Toshiharu
Correia, Luis
Kawashiri, Masa-Aki
Southern, Danielle
DOI
10.1016/j.ijcard.2020.06.021
Abstract
Acute myocardial infarction (AMI) recurrence is still high despite great progress in secondary prevention. Patients with recurrent AMI suffer worse prognosis compared to those with first AMI. The objective was to evaluate the effect of optimal medical therapy (OMT) on these patients with recurrent AMI.